Picture of OptimizeRx logo

OPRX OptimizeRx Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapHigh Flyer

Annual balance sheet for OptimizeRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments10.584.774.113.913.4
Net Total Accounts Receivable
Net Total Receivables17.924.822.237.338.2
Prepaid Expenses
Total Current Assets32.911598.654.354
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.5950.4730.3730.7220.516
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets60.3141135183171
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities109.378.417.918.7
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities10.49.618.5456.854.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity50131126127117
Total Liabilities & Shareholders' Equity60.3141135183171
Total Common Shares Outstanding